It has recently been established that bone marrow-derived endothelial progenitor cells (EPCs) are recruited to the systemic circulation and, in response to various cytokines, pharmacologic agents, and/or tissue ischemia, incorporate into sites of new blood vessel growth (neovascularization). These findings have changed our understanding of adult neovascularization by demonstrating that both preexisting endothelial cells and EPCs contribute to blood vessel formation during adult life. The following review article highlights the discovery of EPCs, their relationship to various clinical diseases, and their therapeutic potential for augmenting blood vessel formation.
ShiQ., RafiiS., WuM.H.Evidence for circulating bone marrow-derived endothelial cells.Blood1998; 92: 362–7.
13.
GunsiliusE., DubaH.C., PetzerA.L.Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells.Lancet2000; 355: 1688–91.
14.
AsaharaT., MasudaH., TakahashiT.Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.Circ Res1999; 85: 221–8.
15.
TakahashiT., KalkaC., MasudaH.Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization.Nat Med1999; 5: 434–8.
16.
ShintaniS., MuroharaT., IkedaH.Mobilization of endothelial progenitor cells in patients with acute myocardial infarction.Circulation2001; 103: 2776–9.
17.
GillM., DiasS., HattoriK.Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells.Circ Res2001; 88: 167–74.
18.
AsaharaT., TakahashiT., MasudaH.VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells.EMBO J1999; 18: 3964–72.
19.
KalkaC., MasudaH., TakahashiT.Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects.Circ Res2000; 86: 1198–202.
20.
KalkaC., TehraniH., LaudenbergB.VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease.Ann Thorac Surg2000; 70: 829–34.
21.
HattoriK., DiasS., HeissigB.Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hema-topoiesis by recruitment of vasculogenic and hematopoietic stem cells.J Exp Med.2001; 193: 1005–14.
TepperO.M., GalianoR.D., CaplaJ.M.Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures.Circulation2002; 106: 2781–6.
24.
VasaM., FichtlschererS., AicherA.Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.Circ Res2001; 89: El-7.
25.
ZhangZ.G., ZhangL., JiangQ., ChoppM.Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ishcemia in the adult mouse.Circ Res2002; 90: 284–8.
KalkaC., MasudaH., TakahashiT.Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.Proc Natl Acad Sci U S A2000; 97: 3422–7.
28.
KawamotoA., GwonH.C., IwaguroH.Therapeutic potential endothelial progenitor cells for of ex vivo expanded myocardial ischemia.Circulation2001; 103: 634–7.
KocherA.A., SchusterM.D., SzabolcsM.J.Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.Nat Med2001; 7: 430–6.
32.
AssmusB., SchachingerV., TeupeC.Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI).Circulation2002; 106: 3009–17.
33.
VasaM., FichtlschererS., AdlerK.Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease.Circulation2001, 103: 2885–90.
34.
WalterD.H., RittigK., BahlmannF.H.Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells.Circulation2002; 105: 3017–24.
DimmelerS., AicherA., VasaM.HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.J Clin Invest2001; 108: 391–7.
37.
CrosbyJ.R., KaminskiW.E., SchattemanG.Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation.Circ Res2000; 87: 728–30.
38.
GrantM.B., MayW.S., CaballeroS.Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization.Nat Med2002; 8: 607–12.
39.
OtaniA., KinderK., EwaltK.Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis.Nat Med2002; 8: 1004–10.
40.
LuM., AdamisA.P.Vascular endothelial growth factor gene regulation and action in diabetic retinopathy.Ophthalmol Clin North Am2002; 15: 69–79.
41.
MancusoP., BurliniA., PrunedG.Resting and activated endothelial cells are increased in the peripheral blood of cancer patients.Blood2001; 97: 3658–61.
42.
MonestiroliS., MancusoP., BurliniA.Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma.Cancer Res2001; 61: 4341–4.
43.
ItoH., RoviraI.I., BloomM.L.Endothelial progenitor cells as putative targets for angiostatin.Cancer Res1999; 59: 5875–7.
44.
RafiiS., HattoriK., LydenD.Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.Nat Med2001; 7: 1194–201.
45.
CapilloM., MancusoP., GobbiA.Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors.Clin Cancer Res2003; 9: 377–82.
46.
ArafatW.O., CasadoE., WangM.Genetically modified CD34+ cells exert a cytotoxic bystander effect on human endothelial and cancer cells.Clin Cancer Res2000; 6: 4442–8.
47.
Gomez-NavarroJ., ContrerasJ.L., ArafatW.Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model.Gene Ther2000; 7: 43–52.
KaushalS., AmielG.E., GuleserianK.J.Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo.Nat Med2001; 7: 1035–40.
50.
TepperO., MurayamaT., SilverM.Bone marrow-derived endothelial progenitor cells contribute to recanalization and resolution of an existing thrombus [abstract].Arterioscler Thromb Vasc Biol2002.
51.
VogelG.Stem cell research. Same results, different interpretations.Science2003; 299: 324.
52.
TeradaN., HamazakiT., OkaM.Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion.Nature2002; 416: 542–5.
53.
YingQ.L., NicholsJ., EvansE.P., SmithA.G.Changing potency by spontaneous fusion.Nature2002; 416: 545–8.
54.
MedvinskyA., SmithA.Stem cells: fusion brings down barriers.Nature2003; 422: 823–5.
